Rett Syndrome: 70 NIH awards ($64.3M) to 40 organizations

Name: NIH and NSF awards on Rett Syndrome
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

70 NIH awards ($64.3M) in the NIH spending category Rett Syndrome, to 40 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Rett Syndrome Watch Rett Syndrome

Topic: NIH spending category

Awards

70 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$4,693,682	February 15, 2021	January 31, 2027	BENKE, TIMOTHY A	reporter.nih.gov
Advancing an XIST ASO candidate for the treatment of Rett Syndrome	NIH	National Institute of Mental Health	2021 to 2025	$3,842,186	July 1, 2019	February 28, 2029	LEE, JEANNIE T	reporter.nih.gov
Dense Analysis of Cortical Circuit Dysfunction in the MECP2-duplication Syndrome of Autism	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$3,332,806	January 1, 2021	December 31, 2025	SMIRNAKIS, STELIOS MANOLIS	reporter.nih.gov
Proteogenetics of Autism Spectrum Disorders	NIH	National Institute of Mental Health	2021 to 2025	$3,288,305	August 1, 2013	June 30, 2027	YATES III, JOHN R	reporter.nih.gov
Elucidating the molecular mechanisms behind human neurodevelopmental disorders using brain organoids	NIH	National Institute of Mental Health	2022 to 2025	$2,876,812	February 16, 2022	December 31, 2026	NOVITCH, BENNETT G	reporter.nih.gov
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders	NIH	National Institute of Mental Health	2021 to 2024	$2,788,139	September 21, 2020	June 30, 2026	NISWENDER, COLLEEN M	reporter.nih.gov
Transcriptional condensates, epigenetic editing and Rett Syndrome	NIH	National Institute of Mental Health	2021 to 2023	$2,677,396	September 15, 2014	July 31, 2025	JAENISCH, RUDOLF	reporter.nih.gov
Noradrenergic mechanisms in breathing and respiratory pathophysiologies	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,520,373	January 15, 2016	July 31, 2025	RAY, RUSSELL S	reporter.nih.gov
Development of Translatable Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$2,464,143	April 1, 2023	March 31, 2026	MARSH, ERIC D	reporter.nih.gov
MeCP2 reactivation from the inactive X chromosome as treatment for Rett syndrome	NIH	National Institute of Mental Health	2023 to 2025	$2,456,289	September 15, 2023	June 30, 2028	LIU, X. SHAWN	reporter.nih.gov
Glial chemosensitivity and control of breathing in Rett syndrome	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,155,960	August 1, 2010	December 31, 2025	MULKEY, DANIEL K	reporter.nih.gov
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROME	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$1,994,213	September 4, 2006	April 30, 2026	ZOGHBI, HUDA Y	reporter.nih.gov
Early developmental mechanisms of Rett Syndrome	NIH	National Institute of Mental Health	2021 to 2025	$1,936,688	December 1, 2009	January 31, 2027	SUR, MRIGANKA	reporter.nih.gov
Understanding the effects of motor learning in wild-type and Mecp2-deficient mice	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2025	$1,912,399	April 1, 2022	March 31, 2027	LU, HUI	reporter.nih.gov
Studying the effects and mechanisms of deep brain stimulation in Rett syndrome mice	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$1,884,390	April 1, 2018	July 31, 2027	TANG, JIANRONG	reporter.nih.gov
Understanding the Pathogenic Mechanisms of Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2025	$1,672,155	September 1, 2013	April 30, 2030	ZHOU, ZHAOLAN	reporter.nih.gov
A precision medicine approach to Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,388,394	May 1, 2020	April 30, 2026	GOGLIOTTI, ROCCO GEORGE	reporter.nih.gov
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$1,366,769	April 1, 2021	August 15, 2025	LI, WEI	reporter.nih.gov
Repair of neurological disorders through RNA editing	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,337,395	December 1, 2019	November 30, 2024	MANDEL, GAIL	reporter.nih.gov
Targeted Therapies for Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,175,897	May 1, 2019	April 30, 2025	KANNAN, SUJATHA	reporter.nih.gov
Neuroimmune interactions in Rett syndrome	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2022	$1,146,682	September 10, 2018	June 30, 2024	LASALLE, JANINE M	reporter.nih.gov
Restoration of Homeostasis of Downstream Targets of MeCP2 as a Potential Therapeutic Avenue for Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$984,375	March 1, 2019	January 31, 2025	MACDONALD, JESSICA L.	reporter.nih.gov
Elucidating the role of MeCP2 in the pathophysiology of obesity	NIH	National Institute of General Medical Sciences	2022 to 2024	$886,350	July 8, 2022	May 31, 2026	NA, ELISA S	reporter.nih.gov
Role of the Hippocampal-mPFC Pathway in Social Memory Deficits in Autism	NIH	National Institute of Mental Health	2021 to 2022	$851,655	April 1, 2019	January 31, 2024	POZZO-MILLER, LUCAS D	reporter.nih.gov
Comprehensive Deep Phenotyping and Multi-omics to Develop Clinical and Molecular Biomarkers for MeCP2-related Diseases	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2025	$841,256	August 15, 2022	June 30, 2027	PEHLIVAN, DAVUT	reporter.nih.gov
Investigating mitochondrial dysfunction in human astrocytes with RTT-causing MECP2 mutations	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$797,500	May 5, 2024	April 30, 2029	BALLAS, NURIT	reporter.nih.gov
Preclinical development of novel site blocking ASOs for the treatment of Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2025	$774,361	August 1, 2025	July 31, 2027	GOGLIOTTI, ROCCO GEORGE	reporter.nih.gov
High Fidelity Genome Editing for the Correction of MECP2 Mutations and Physiologic Regulation of Expression in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2025	$738,182	April 15, 2025	February 28, 2030	CHATTERJEE, SASWATI	reporter.nih.gov
Application of a novel dCasNano-based Epigenetic Editing to Treat Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2024	$698,459	September 15, 2024	February 28, 2026	TSAI, YI-TING	reporter.nih.gov
Disruption of lateralized auditory cortical function in a mouse model of Rett Syndrome	NIH	National Institute on Deafness and Other Communication Disorders	2024	$530,706	March 1, 2024	February 28, 2025	OVIEDO, HYSELL VIVIANA	reporter.nih.gov
Contribution of astrocytes to Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2024	$522,500	June 1, 2024	May 31, 2026	ALLEN, NICOLA J	reporter.nih.gov
Restoring Cortical Network Function in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$515,462	January 1, 2024	December 31, 2028	MIERAU, SUSANNA	reporter.nih.gov
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes	NIH	National Institute of Mental Health	2021 to 2022	$491,612	April 1, 2020	January 31, 2023	LIU, X. SHAWN	reporter.nih.gov
Clinical validation of at-home methods of sleep assessment in Rett Syndrome	NIH	National Center for Advancing Translational Sciences	2021 to 2022	$457,700	July 1, 2021	April 30, 2024	PETERS, SARIKA U	reporter.nih.gov
High dimensional motor coding and motor dysfunction in Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2024	$450,000	July 9, 2024	June 30, 2027	SHEW, WOODROW L.	reporter.nih.gov
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools	NIH	National Institute on Drug Abuse	2022 to 2023	$444,125	August 1, 2022	July 31, 2024	SHEN, YIN	reporter.nih.gov
The cellular and molecular signatures of postnatal human RTT astrocytes	NIH	National Institute of Mental Health	2021 to 2022	$438,625	April 1, 2021	March 31, 2025	BALLAS, NURIT	reporter.nih.gov
Single-cell approaches to probe the function of the unique neuronal epigenome	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$433,125	March 1, 2022	February 28, 2025	EDWARDS, JOHN R.	reporter.nih.gov
miRNA site-blocking ASOs as MeCP2 targeted therapeutics	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2024	$423,500	April 4, 2023	March 31, 2026	GOGLIOTTI, ROCCO GEORGE	reporter.nih.gov
Role of GABAergic interneurons in developmental dysregulation of cortical function	NIH	National Institute of Mental Health	2021	$418,210	August 3, 2017	May 31, 2023	CARDIN, JESSICA A	reporter.nih.gov
How MeCP2 discriminates epigenetic marks is still a mystery	NIH	National Institute of General Medical Sciences	2021	$334,000	July 1, 2018	June 30, 2023	BRENOWITZ, MICHAEL D.	reporter.nih.gov
Mitochondrial ROS and Microglia in Rett Syndrome	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$314,989	August 10, 2017	May 31, 2022	JIN, LEE-WAY	reporter.nih.gov
Function of stimulus-induced MeCP2 phosphorylation	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$311,125	April 1, 2010	April 30, 2024	CHANG, QIANG	reporter.nih.gov
Developing multimodal biomarkers of cognitive ability in a genetic model of neurodevelopment	NIH	National Institute of Mental Health	2023 to 2025	$232,923	December 3, 2020	July 31, 2026	CAZARES, CHRISTIAN	reporter.nih.gov
Development of a reliable, valid, and sensitive outcome measure in Rett syndrome	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$219,524	September 1, 2020	August 31, 2023	NEUL, JEFFREY L	reporter.nih.gov
CONTROL OF LONG GENE EXPRESSION AS A NOVEL THERAPEUTIC APPROACH FOR RETT SYNDROME	NIH	National Institute of Neurological Disorders and Stroke	2021	$197,640	December 11, 2019	June 30, 2022	RENTHAL, WILLIAM RUSSELL	reporter.nih.gov
Genetic enhancement of CREB signaling in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021	$194,375	August 1, 2020	June 30, 2023	TIBBETTS, RANDAL SCOT	reporter.nih.gov
Single-molecule Investigation of the Interaction Between MeCP2 and Chromatin	NIH	National Institute of Mental Health	2022 to 2024	$143,420	September 1, 2022	August 31, 2025	CHUA, GABRIELLA N. L.	reporter.nih.gov
Examining adult hippocampal neurogenesis and cognitive function in Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$139,374	May 1, 2022	April 30, 2024	ANDERSON, ASHLEY GRACE	reporter.nih.gov
Contributions of Astrocyte Kir4.1/5.1 Channels to Disordered Breathing in Rett Syndrome	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$137,266	January 6, 2023	January 5, 2027	STRAIN, MONICA	reporter.nih.gov
Targeting MeCP2-Associated Disorders with miRNA Site-Blocking Oligonucleotides	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2024 to 2025	$136,336	May 1, 2024	January 6, 2026	VANDERPLOW, AMANDA	reporter.nih.gov
Astrocyte-neuron interactions in Rett Syndrome and Fragile X Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2025	$118,395	August 7, 2025	February 28, 2027	LYON, KRISTINE ANNE	reporter.nih.gov
Circulating Organ-enriched microRNAs as biomarkers of Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021	$110,956	September 30, 2020	March 30, 2023	UMANSKY, SAMUIL R	reporter.nih.gov
Epigenetic and Neuronal Mechanisms of MECP2 Reactivation to rescue Rett Syndrome	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2024 to 2025	$101,915	September 16, 2024	September 15, 2028	PAN, RICHARD LI CHENG	reporter.nih.gov
Characterization of functional molecular domains of MeCP2	NIH	National Institute of Mental Health	2021 to 2022	$96,176	August 1, 2020	May 12, 2023	COLLINS, BRIDGET E	reporter.nih.gov
Characterization of MeCP2-dependent gene regulation with temporal and mechanistic precision	NIH	National Institute of Neurological Disorders and Stroke	2021	$89,370	June 1, 2021	May 31, 2022	BOXER, LISA D.	reporter.nih.gov
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2025	$89,132	April 1, 2021	December 31, 2026	LI, WEI	reporter.nih.gov
The role of skull bone marrow-derived CNS macrophages in Rett syndrome.	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$87,881	November 1, 2023	October 31, 2025	MAZZITELLI PEREZ, JOSE ALEJANDRO	reporter.nih.gov
The interplay of the heat shock cascade and Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$85,712	April 15, 2024	August 31, 2026	GONZALEZ, SONIA	reporter.nih.gov
MeCP2 and non-CG methylation regulation of neuronal cell-type specific transcription	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2022	$83,722	March 1, 2021	February 28, 2023	MOORE, JAMES RUSSELL	reporter.nih.gov
BDNF signaling via astrocyte Trkb.T1 drives morphogenesis and maturation of astrocytes, a dysregulated feature of Rett syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$82,705	July 10, 2021	July 9, 2023	HERNANDEZ, RAYMUNDO DANIEL	reporter.nih.gov
Exploring the role of hippocampal hypervascularization in Rett syndrome pathogenesis	NIH	National Institute of Neurological Disorders and Stroke	2025	$75,520	September 1, 2025	August 31, 2028	BRENNER, JOSHUA	reporter.nih.gov
Establishing and Optimizing a Prime Editing Method in Neurons for Treatment of Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$73,206	January 15, 2023	February 3, 2025	KEENER, DAVID G.	reporter.nih.gov
Lipid dysregulation as a mediator of Rett syndrome disease progression	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$65,994	April 24, 2021	April 23, 2022	NEIER, KARI ELIZABETH	reporter.nih.gov
Identifying potential therapeutics for neurodevelopmental disorders using artificial intelligence and transcriptional data	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2024	$49,362	December 1, 2024	May 31, 2028	DEISSEROTH, COLE	reporter.nih.gov
Investigating the role of Growth-differentiation factor 11 in neurodevelopmental and MECP2-related disorders	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$35,229	September 10, 2019	March 9, 2022	BAJIKAR, SAMEER	reporter.nih.gov
Uncovering functional nodes of the Rett syndrome transcriptome	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022	$34,290	March 1, 2023	February 28, 2024	CONNOLLY, DANIEL	reporter.nih.gov
Aberrant parvalbumin-positive interneuron regulation of maternal behavior in a Rett Syndrome mouse model	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022	$32,410	September 20, 2022	May 31, 2023	PAGLIARO, ALEXA	reporter.nih.gov
Stratifying Rett syndrome patient populations to evaluate the efficacy of genetic and pharmacological therapeutic interventions	NIH	National Institute of Mental Health	2021	$30,751	August 1, 2019	July 31, 2022	VERMUDEZ, SHERYL ANNE DAGUIMOL	reporter.nih.gov
Functional Connectivity Across Development in a Mouse Model of Rett Syndrome	NIH	National Institute of Neurological Disorders and Stroke	2021	$8,191	July 1, 2019	August 19, 2021	RAHN, RACHEL M	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Baylor College of Medicine	Houston, TX	8	$7.5 million	$0
University of Colorado Denver	Aurora, CO	1	$4.7 million	$0
Brigham and Women's Hospital	Boston, MA	3	$4 million	$0
Massachusetts General Hospital	Boston, MA	1	$3.8 million	$0
Scripps Research Institute, the	La Jolla, CA	1	$3.3 million	$0
Columbia University Health Sciences	New York, NY	3	$3 million	$0
Vanderbilt University	Nashville, TN	3	$2.9 million	$0
University of California Los Angeles	Los Angeles, CA	1	$2.9 million	$0
Loyola University Chicago	Maywood, IL	5	$2.8 million	$0
Whitehead Institute for Biomedical Res	Cambridge, MA	1	$2.7 million	$0
Children's Hosp of Philadelphia	Philadelphia, PA	1	$2.5 million	$0
University of Connecticut	Storrs, CT	2	$2.3 million	$0
University of Alabama at Birmingham	Birmingham, AL	2	$2.2 million	$0
Massachusetts Institute of Technology	Cambridge, MA	1	$1.9 million	$0
George Washington University	Washington, DC	1	$1.9 million	$0
University of Pennsylvania	Philadelphia, PA	2	$1.7 million	$0
University of California at Davis	Davis, CA	3	$1.5 million	$0
Oregon Health & Science University	Portland, OR	1	$1.3 million	$0
SUNY at Stony Brook	Stony Brook, NY	2	$1.2 million	$0
Johns Hopkins University	Baltimore, MD	1	$1.2 million	$0
Washington University	Saint Louis, MO	5	$1.1 million	$0
Syracuse University	Syracuse, NY	1	$984,375	$0
Texas Woman's University	Denton, TX	1	$886,350	$0
Beckman Research Institute/city of Hope	Duarte, CA	1	$738,182	$0
Epitor Therapeutics, Inc.	New York, NY	1	$698,459	$0
Vanderbilt University Medical Center	Nashville, TN	2	$677,224	$0
Salk Institute for Biological Studies	La Jolla, CA	2	$640,895	$0
University of Wisconsin-Madison	Madison, WI	2	$505,500	$0
University of Arkansas	Fayetteville, AR	1	$450,000	$0
University of California, San Francisco	San Francisco, CA	1	$444,125	$0
Yale University	New Haven, CT	1	$418,210	$0
Albert Einstein College of Medicine	Bronx, NY	1	$334,000	$0
University of California, San Diego	La Jolla, CA	1	$232,923	$0
Rockefeller University	New York, NY	1	$143,420	$0
Diamir, LLC	Princeton, NJ	1	$110,956	$0
Harvard Medical School	Boston, MA	1	$89,370	$0
Henry Ford Health + Michigan State University Health Sciences	East Lansing, MI	1	$89,132	$0
Virginia Polytechnic Institute and State University	Blacksburg, VA	1	$82,705	$0
Univ of Massachusetts Med SCH Worcester	Worcester, MA	1	$73,206	$0
Cold Spring Harbor Laboratory	Cold Spring Harbor, NY	1	$32,410	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	28	$10,676,893	$0
2024	33	$13,454,697	$0
2023	32	$13,575,461	$0
2022	35	$13,418,068	$0
2021	37	$13,195,546	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)	PA-24-254	NIH		July 12, 2027	Not listed	Notice number printed on 1 award here
Functional Target Validation for Alzheimer's Disease-Related Dementias	RFA-NS-26-034	NIH	93.853	November 6, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)	PAR-27-007	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)	RFA-NS-26-001	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)	RFA-NS-26-030	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)	PAR-25-052	NIH	93.853	November 19, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)	RFA-AT-25-003	NIH	93.853	November 23, 2026	$375,000	Same assistance listing 93.853 as 33 awards here
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)	RFA-OD-27-008	NIH	93.853	December 2, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)	PAR-24-295	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)	PAR-24-296	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.853	December 4, 2026	Not listed	Same assistance listing 93.853 as 33 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.853	January 7, 2027	$375,000	Same assistance listing 93.853 as 33 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.853	January 15, 2027	$350,000	Same assistance listing 93.853 as 33 awards here
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)	RFA-DA-28-011	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 33 awards here
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)	RFA-DA-28-012	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 33 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)	PAR-24-268	NIH	93.853	January 27, 2027	$500,000	Same assistance listing 93.853 as 33 awards here
Translational Neural Devices (R61/R33 - Clinical Trial Optional)	PAR-25-053	NIH	93.853	January 28, 2027	Not listed	Same assistance listing 93.853 as 33 awards here
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)	RFA-NS-24-031	NIH	93.853	January 28, 2027	$750,000	Same assistance listing 93.853 as 33 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.